A comparison of medication administration errors from original medication packaging and multi-compartment compliance aids in care homes: A prospective observational study by Gilmartin-Thomas, JF-M et al.
1 
 
A comparison of medication administration errors from original medication packaging and multi-
compartment compliance aids in care homes: a prospective observational study 
ABSTRACT 
Background 
No published study has been specifically designed to compare medication administration errors 
between original medication packaging and multi-compartment compliance aids in care homes, 
using direct observation.  
Objectives 
Compare the effect of original medication packaging and multi-compartment compliance aids on 
medication administration accuracy. 
Design 
Prospective observational. 
Setting 
Ten Greater London care homes.  
Participants 
Nurses and carers administering medications. 
Methods 
Between October 2014 and June 2015, a pharmacist researcher directly observed solid, orally 
administered medications in tablet or capsule form at ten purposively sampled care homes (five only 
used original medication packaging and five used both multi-compartment compliance aids and 
original medication packaging). The medication administration error rate was calculated as the 
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number of observed doses administered (or omitted) in error according to medication 
administration records, compared to the opportunities for error (total number of observed doses 
plus omitted doses). 
Results  
Over 108.4 hours, 42 staff (36 nurses, 6 carers) were observed to administer medications to 823 
residents during 90 medication administration rounds. A total of 2,452 medication doses were 
observed (1,385 from original medication packaging, 1,067 from multi-compartment compliance 
aids). One hundred and seventy eight medication administration errors were identified from 2,493 
opportunities for error (7.1% overall medication administration error rate). A greater medication 
administration error rate was seen for original medication packaging than multi-compartment 
compliance aids (9.3% and 3.1% respectively, risk ratio (RR)=3.9, 95% confidence interval (CI) 2.4 to 
6.1, p<0.001). Similar differences existed when comparing medication administration error rates 
between original medication packaging (from original medication packaging-only care homes) and 
multi-compartment compliance aids (RR=2.3, 95%CI 1.1 to 4.9, p=0.03), and between original 
medication packaging and multi-compartment compliance aids within care homes that used a 
combination of both medication administration systems (RR=4.3, 95%CI 2.7 to 6.8, p<0.001). A 
significant difference in error rate was not observed between use of a single or combination 
medication administration system (p>0.05). 
Conclusion 
The significant difference in, and high overall, medication administration error rate between original 
medication packaging and multi-compartment compliance aids supports the use of the latter in care 
homes, as well as local investigation of tablet and capsule impact on medication administration 
errors and staff training to prevent errors occurring. As a significant difference in error rate was not 
observed between use of a single or combination medication administration system, common 
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practice of using both multi-compartment compliance aids (for most medications) and original 
packaging (for medications with stability issues) is supported.  
Key words 
Medication errors, medication safety, nurses, nursing homes  
What is known about this subject 
 Systems that endeavour to improve medication supply to older populations, such as multi-
compartment compliance aids (MCAs), via increased efficiency, ease of use, reduced costs 
and errors, require regular evaluation. 
 Though MCA systems are commonly used by care homes for medication administration, 
they have not been regularly or extensively evaluated. 
What this study adds 
 The significant difference in, and high overall, medication administration error rate between 
original medication packaging and multi-compartment compliance aids supports the use of 
the latter in care homes, as well as local investigation of tablet and capsule impact on 
medication administration errors and staff training to prevent errors occurring. 
 As a significant difference in error rate was not observed between use of a single or 
combination medication administration system, common practice of using both multi-
compartment compliance aids (most medications) and original packaging (for medications 
with stability issues) is supported. 
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INTRODUCTION 
Care home (CH) medication administration systems should be regularly evaluated to ensure a high 
standard of care and to minimise errors associated with their use.1 A key variable in assessing health 
care facility medication systems is whether patients receive medications as prescribed.2 Despite the 
high reliability of observational methods to identify medication administration errors (MAEs),3, 4 few 
studies employing this ethnographic research approach have been published in the CH setting.5 In a 
2013 systematic review of literature examining MAEs identified by observation, 89% (n=81) of the 
studies were conducted in the hospital setting while 11% (n=10) were conducted in long term care 
facilities (including nursing/care/assisted living homes).5 Of the 10 studies, only one was conducted 
in the UK (USA n=6, Netherlands n=2, Belgium n=1), the majority (n=7) included 12 or less CHs in 
their sample, and the majority (n=6) either did not specify the duration of observation or observed 
medication administration for approximately 25 days or less.5 No study was specifically designed to 
observe only tablet or capsule oral administration (all 10 studies observed all routes of 
administration) and two studies used disguised observation while the remaining eight did not specify 
the type of observation.5 It is a limitation that only two studies used the medication expertise of 
pharmacist observers (although the majority used observers with a pharmacy background n= 5), 
while remaining studies used nurses (n=3) or observers from the Department of Health (n=1) or a 
Consulting Agency (n=1).5 Nurses or nursing staff were observed in six studies and the remaining 
studies observed other staff at the CH.5 It is a strength that a uniform method for calculating and 
reporting MAE rates was used in all studies, where the numerator related to the number of doses 
with one or more medication errors and the denominator corresponded to the total opportunities 
for error.5 
It is difficult to apply findings arising from hospital-based research to CHs due to significant 
differences in support structures within the respective work environments, facilities available and 
the level of education and training of staff. When conducting research in CHs, unique complexities 
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arise from the interaction between the residential and medical aspects of the CH environment.6 Care 
homes are a complex healthcare setting, where a home-like environment is created, while also 
incorporating processes and protocols to facilitate efficient and effective healthcare delivery by 
onsite staff and visiting healthcare professionals. Compared to a hospital environment, CH residents 
may be cared for by staff who have varying levels of education and skills related to healthcare 
provision, and varying access to prompt, specialist healthcare support and advice. 
The Care Home Use of Medicines Study (CHUMS) established the prevalence, types and underlying 
causes of medication errors in CHs in England.1, 7 Of the 256 residents from 55 CHs involved in 
CHUMS, 69.5% had at least one medication error.1 The prevalence of MAEs by opportunity for error 
was 8.4% (involving all administered medication formulations including solid oral, liquid, topical 
medications) and 22.3% of residents were observed to be exposed to a MAE.1 Alldred et al also 
identified in adjusted analyses of CHUMS data that there was a statistically significant doubling of 
the odds of a MAE for tablets and capsules administered from original packaging (OP) compared to 
multi-compartment compliance aid (MCA) medication administration systems (odds ratio=2.14, 95% 
confidence interval (CI)=1.02 to 4.51). 8 However, CHUMS was not specifically designed to compare 
the accuracy of medication administration between these two medication administration systems.8 
CHUMS recommended that research should be conducted into the effectiveness of MCAs.7 This 
limitation has been addressed in the current study.  
In UK CHs, MCAs are commonly prepared by pharmacy staff at pharmacies and delivered to CHs. 
They assist CH staff with managing large volumes of medications9 by organising medications 
according to the day of the week and time of the day in which they must be administered. Different 
types of MCAs exist worldwide, however, UK CHs commonly use MCAs that may be referred to as 
unit-dose, bubble pocket blister packs. The 28 clear plastic bubble pockets on a single MCA each 
contain the same medication to be administered at a specific dosing interval (e.g. breakfast, lunch, 
dinner or bedtime) for every day of the week, for 28 days. The plastic bubble is pushed to force 
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medications through the paper backing of the MCA and into an administration device. A resident’s 
entire medication regimen may be contained within multiple MCAs, which correspond to different 
medications, and which are to be given at different dosing intervals. 
  
Limitations associated with the use of MCAs have been identified by pharmacists, including reduced 
staff alertness during medication administration, restricted ability to identify medications and 
medication wastage.10 Pharmacists predict continued use of MCAs in the future due to their 
perceived benefits of improved safety and efficiency.10 This is despite the Royal Pharmaceutical 
Societies of England and Scotland cautioning against the routine use of MCAs, calling for a need to 
review the value of their continued use,11 taking into account the evidence-base for their 
effectiveness as one medication adherence intervention amongst many.12 Published research has 
also explored pharmacist perceptions of stability issues associated with medications packed into 
MCAs13 and pharmacy dispensing incidents associated with their preparation.14 
 
The aim of this study was to use a prospective observational study design to compare the effect of 
OP and MCAs on the accuracy of medication administration in nursing and residential CHs located in 
Greater London.  
 
METHODS 
Sampling strategy 
This study was powered to identify a difference in how accurately medications are administered 
from OP and MCAs. Accuracy was determined by identifying discrepancies (i.e. MAEs) between 
observed, solid, orally administered medications in tablet or capsule form and information contained 
on medication administration records (MARs). A required sample size was calculated to detect the 
difference in MAE rates as seen in previously published literature, where MAE rates of 6.9% (OP) and 
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4.2% (MCAs) have been reported.1 The required sample size was 2,246 doses of observed solid, 
orally administered medications in tablet or capsule form (1,123 doses from each of OP and MCAs), 
calculated with a power of 80% and p=0.05. Assuming that the average number of medications 
prescribed per resident, and number of residents per CH, was 7 and 30 respectively,1 10 CHs were 
recruited. Of these 10 CHs, five CHs only used OP and five CHs used both MCAs and OP. Where 
MCAs are used to administer medications in CHs, OP must also be used for medications that cannot 
be repackaged into MCAs (e.g. due to stability concerns). It was estimated that 230 doses would be 
observed at each CH to achieve the required sample size of observed doses.  
Residential CHs (provide daily care and support for activities of daily living such as washing and 
dressing) and nursing CHs (provide 24-hour care from a qualified nurse) that accommodated older 
people, and where medications were administered by staff, were sampled purposively from around 
Greater London.15 Both residential CHs and nursing CHs were involved in this study. The researcher 
observed both nurses and carers administer medications, as a statistically significant difference in 
MAE rates between nurses and carers was not identified in CHUMS (although CHUMS was not 
designed to detect such a difference).1  
CHs were identified via: the website of the Care Quality Commission, the independent regulator of 
health and adult social care in England (http://www.cqc.org.uk/); staff who worked at CHs 
participating in the study; and personal contacts of the research team, such as pharmacists who 
themselves worked with CHs or had colleagues who worked with CHs. As relatively few CHs in 
England administer medications from only OP, these CHs were purposively identified and recruited 
(e.g. by contacting CHs that were part of a franchise known to administer medications from only 
OP). 
Recruitment 
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The research team contacted managers or deputy managers of each CH via telephone to ascertain 
initial interest in the study. Study information, including a letter of invitation, information sheet and 
reply slip was subsequently sent via email. Interested CHs were personally visited by the researcher 
to formalise recruitment and to introduce themselves to managers or deputy managers of the CH 
and staff involved in medication administration. Additionally, the researcher provided study 
information to staff involved in medication administration, including a letter of invitation, 
information sheet and consent form, answered questions about the study, obtained practical 
information to guide data collection e.g. visit dates and times, and familiarised themselves with the 
CH layout. 
Data collection instrument 
The data collection protocol and instruments were developed in conjunction with the research team, 
with reference to templates from previously conducted studies involving CH medication audits.1, 14 
The research team had expertise in relevant research methods and previous experience of 
undertaking research in CHs. Information collected included: the time of medication administration; 
resident age and gender; administered medication name and strength; if the medication was 
administered from an OP or MCA; whether the administered medication was a tablet or capsule and 
its quantity; if the medication was crushed; if the staff administering medications observed and 
signed for administration; and if the administered medication matched information contained on 
the MAR and details of any discrepancies identified. It was anticipated that collection of information 
regarding resident characteristics (other than gender, age and medication information) would have 
required individual resident study consent. As this was not feasible, ethical approval was not 
obtained to collect these data. With regards to the model of care involved at each CH, information 
collected included the type of care provided (nursing or residential), medication administration 
system in use (OP or MCA, single or combination system) and information about staff administering 
medications (nurse or carer, gender, years of experience, country of qualification). Observed barriers 
9 
 
and facilitators with regards to the overall process of medication administration were also recorded. 
Data collection instruments were assessed for face and content validity by the research team and 
were piloted in one CH. Following the pilot, recorded data were reviewed to ensure the study aim 
was being met, and to assess the appropriateness of data collection instruments and procedures. 
Minor formatting changes were made to data collection instruments for ease of recording.  
Data collection procedure 
On each day of data collection, the pharmacist researcher aimed to arrive at the CH just before the 
morning hand-over meeting. During this time, staff would congregate in preparation for the hand-
over meeting and could be easily located in the CH. Additionally, the breakfast medication 
administration round, when the largest quantity of medications are usually administered, would not 
have commenced. The researcher gave staff administering medications written study information 
and time to consider study involvement.  
When a signed consent form was obtained, staff were observed administering medications during 
the breakfast, lunch, dinner and/or any additional morning/afternoon medication administration 
rounds. To prevent changes in nurse or carer behaviour as a result of the research pharmacist being 
present, the researcher did not interfere with medication administration and only spoke with staff 
where appropriate, such as when clarifying the identity of an administered medication (if this could 
not be determined from medication labels). Additionally, the researcher: established rapport with 
the nurse or carer and asked them to administer medications as they normally would; maintained an 
appropriate distance between themselves and the nurse or carer while they were preparing 
medications for administration; and limited opportunities for staff to observe them taking notes. 
Information regarding observed solid, orally administered medications in tablet or capsule form was 
identified from labels affixed to OP and MCAs or by asking staff, and recorded at the time of 
administration. These labels included information about the medication name, strength, form and 
formulation. As a result of referring to medication labels or asking staff, as well as observing 
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medication preparation for all recorded observations, the research pharmacist always knew what 
medications were being administered from OP or MCAs. Additionally, medication labels, which were 
attached to all OP or MCAs, were referred to by nurses or carers, to ensure that the correct 
medication had been supplied. Observed medication doses could include both ‘regular’ and ‘when 
required’ medications. Due to issues of privacy (e.g. if the resident was not dressed) or under staff 
instruction (e.g. if staff did not feel it was appropriate for the pharmacist researcher to observe the 
resident, based on their knowledge of the resident’s personality or preferences), medication 
consumption by the resident was not always observed. However, the pharmacist researcher clarified 
with staff if the resident actually consumed the medication.  
Individual staff were observed once, during a single medication administration round (e.g. Monday 
breakfast), or they were observed more than once, during multiple medication administration 
rounds on the same day (e.g. Monday breakfast and lunch) or over different days (e.g. Monday 
breakfast and Tuesday breakfast). The number of different staff observed was dependent on the 
number of staff administering medications on a particular day and their willingness to be involved in 
the study. The number of days (up to four) and length of time spent each day, at each CH, was 
guided by the requirement to observe approximately 230 solid, orally administered medication 
doses in tablet or capsule form per CH. The length of the observation period at each CH varied (both 
between CHs and within individual CHs) and was influenced by factors such as: the number of 
residents in the CH who required medication administration and the number of medications each 
resident was prescribed, and the number of residents (and the number of medications per resident) 
an individual nurse or carer had to administer medications to at each medication administration 
round.  
Where possible, entire medication administration rounds were observed, except where rounds had 
already commenced or the researcher had to leave the CH early. Observations concluded when the 
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staff administering medications said that the round had finished, even if some residents still required 
medication administration, such as after earlier refusal. 
The process of administering medications usually began when the nurse or carer collected the 
medication administration trolley, and all residents’ medications and MARs from a secure 
medication room. The trolley would then be transported to each resident who required medications 
to be administered at that time of day. Information contained within a resident’s specific MAR was 
used to prepare their medications for administration. As the nurse or carer read each medication to 
be administered, they would locate the corresponding OP or MCA and transfer the required 
medication dose into an administration device (e.g. medication cup or spoon). This transfer process 
often involved either opening the lid of an OP and selecting the medication dose, or, popping the 
medications out of a bubble pocket (through the paper backing) of a blister pack MCA. Medications 
were then given to residents to consume. Either immediately prior, or following medication 
consumption, the nurse or carer signed the MAR to indicate that a medication had been 
administered. 
Classifying medication administration errors 
At the conclusion of the medication administration round, the researcher compared their recorded 
observations with information contained on the MAR to identify discrepancies. If, and when a 
serious discrepancy was identified, staff were notified. This is consistent with methodology used 
previously.1 Discrepancies that occurred as a result of staff exercising their clinical judgement during 
medication administration, and which were documented on the MAR or communicated to the 
researcher verbally, were not recorded as MAEs.  Observed MAEs were classified into the following 
types:1 omission, allergy inaccuracy, extra dose, wrong dose, un-prescribed medication, medication 
incorrect, formulation incorrect, timing inaccuracy (for time-critical medications only), or ‘other’ 
error (e.g. crushing a modified release formulation) (Table 1).  
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Table 1. Medication administration error types. 
MAE types Explanation 
 
Omission A medication dose that was not observed to be administered during 
the MAR-specified medication administration round.  
Allergy inaccuracy Administration of a medication for which the resident has a known 
allergy (as recorded on the MAR). 
Extra dose Administration of an additional dose of a prescribed medication e.g. 
administration of a medication dose after it has been ceased. 
Wrong dose Administration of a medication in a quantity that was not prescribed 
e.g. administration of incorrect number of dose units or medication 
strength.  
Un-prescribed 
medication 
Administration of a medication that was not prescribed (classified as a 
‘medication incorrect’ inaccuracy if medication X prescribed but 
medication Y administered instead).  
Medication 
incorrect 
Administration of a medication that is not the medication prescribed.  
Formulation 
incorrect 
Administration of a medication in a formulation that was not 
prescribed e.g. administration of a modified release when a non-
modified release was prescribed.  
Timing inaccuracy Antibiotics or levodopa-containing medications administered >1 hour 
outside the time prescribed on the MAR. 
‘Other’ Any other inaccuracy that is not covered above e.g. administering a 
medication with food despite its requirement to be administered on 
an empty stomach, crushing or splitting an enteric coated or modified 
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release formulation, and administering a bisphosphonate with other 
medications. 
MAE - medication administration error; MAR - medication administration record. 
 
The MAE rate was calculated as the number of observed doses administered (or omitted) in error 
compared to the opportunities for error (total number of observed doses plus omitted doses).8, 16 
This definition is consistent with previously conducted studies.5 The British National Formulary17 was 
used as a reference, for example, to identify medications with food-specific administration 
requirements.  
Data analysis 
The Stata 14 statistical software package was used to analyse quantitative data. Quantitative data 
were summarized with descriptive statistics such as percentages, medians and ranges as 
appropriate. A four-level hierarchical Poisson regression model was fitted to the number of MAEs 
with the total opportunities for error as the rate denominator included as an offset term. The 
hierarchy observed was observations of a residents’ medication administration, i.e. multiple 
medications per resident, with residents clustered by medication administrator and then within CHs. 
Type of medication administration system (OP/MCA) was included in the model as a three-category 
explanatory variable according to CH system as: OP use in OP-only CH; OP use in combination CH 
(where both OP and MCA are used); MCA use in a combination CH (where both OP and MCA are 
used). In secondary analyses using the same general model structure, type of CH was included as a 
binary explanatory variable (nursing CH versus residential CH). Other potentially confounding 
variables were examined subsequently in a similar fashion. In other secondary analyses, the models 
were restricted to nursing CHs only. The World Health Organization Anatomical Therapeutic 
Chemical Classification System (ATC) was used to classify observed administered medications.18 
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Ethical approval 
Ethical approval was obtained from the University Research Ethics Committee. Consent was not 
required from residents in order to observe medication administration, or view their medications 
and MARs. Residents were provided with study information upon request, or if they enquired about 
the presence of the pharmacist researcher at the CH. If residents requested that their medication 
administration was not observed, their wishes were respected. Consent was required from staff who 
were observed as they administered medications. 
RESULTS 
Recruitment 
Thirty-nine CHs were contacted to recruit 10 (25.6% recruitment rate). Of CHs that provided reasons 
for non-participation, some reasons included that the CH: already received pharmacy services; had 
recently changed medication administration system; did not have a patient participation platform to 
support research; had their own internal audits; and was in the middle of a refurbishment. Of the 10 
recruited CHs, eight were classified as nursing and two were residential CHs. As per the purposive 
sampling strategy, five CHs administered medications only from OP (all nursing) and five CHs 
administered medications from both MCAs and OP (three nursing and two residential).  
Observations 
Observations were conducted over a total of 30 days, between October 2014 and June 2015. 
Medications were observed to be administered to 823 residents during 90 medication 
administration rounds, lasting a total of approximately 108.4 hours (6,503 minutes) (Table 2). Doses 
administered from OP were observed at all ten CHs (including CHs that only used OP and CHs that 
used both MCAs and OP). Doses administered from MCAs were only observed at the five CHs that 
used both MCAs and OP.   
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Table 2. Medication administration errors by care home.  1 
CH code 
 
1 2 3 4 5 6 7 8 9 10 
CH classification Nursing Nursing Nursing Nursing Nursing Nursing Residential Residential Nursing Nursing 
CH location in Greater London Central Central South Central West North North North Central North 
Total days of observation 3 3 3 3 2 4 3 3 3 3 
Total rounds observed 6 8 12 8 6 12 12 7 9 10 
Total time observed (minutes) 538 431 631 768 615 1,056 466 364 737 897 
Staff observed Nurses Nurses Nurses Nurses Nurses Nurses Carers Carers Nurses Nurses 
Total (different) staff observed 4 5 6 4 3 7 3 3 3 3 
Total residents observed 67 47 78 62 75 166 91 60 84 93 
Medication administration 
system 
OP OP OP OP OP OP/MCA OP/MCA OP/MCA OP/MCA OP/MCA 
Total observed doses  236 142 235 197 241 482 257 196 226 240 
Observed doses by system 
(OP/MCA) 
236 0 142 0 235 0 197 0 241 0 152 330 60 197 35 161 40 186 47 193 
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Total omitted doses by system 
(OP/MCA/unsure*) 
2 0 0 1 0 0 5 0 0 0 0 0 5 0 0 2 0 2 6 6 8 0 0 0 0 0 1 0 0 3 
Total opportunities for error 
(OP/MCA/overall) 
2
3
8 
0 2
3
8 
1
4
3 
0 1
4
3 
2
4
0 
0 2
4
0 
1
9
7 
0 1
9
7 
2
4
6 
0 2
4
6 
1
5
4 
3
3
0 
4
8
6 
6
6 
2
0
3 
2
7
7 
3
5 
1
6
1 
1
9
6 
4
0 
1
8
6 
2
2
7 
4
7 
1
9
3 
2
4
3 
Total MAEs 
(OP/MCA/unsure) 
5 0 0 5 0 0 2
1 
0 0 1
6 
0 0 3
9 
0 0 1
8 
6 2 1
3 
1
5 
8 6 1 0 4 5 1 4 6 3 
Overall MAE rate per CH (%) 2.1 3.5 8.8 8.1 15.9 5.3 13.0 3.6 4.4 5.3 
CH - care home; OP - original packaging; MCA - multi-compartment compliance aid; MAE - medication administration error. 
* cannot infer which medication administration system the medication would have been administered from (because both OP and MCAs were being used at the CH) 
2 
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Overall, each medication administration round lasted a median of approximately 65 minutes (range: 
8-245 minutes). The median duration of the breakfast round was 118.5 minutes (range: 50-245), 
lunch 40 minutes (range: 13-90), dinner 63 minutes (range: 8-115), and the median duration of extra 
morning or afternoon rounds observed was 23 minutes (range: 15-23) (all approximates).   
Of the 823 residents whose medication administration was observed, 338 residents were observed 
once and 485 residents were observed more than once. Six hundred and seventy two residents were 
living in nursing CHs while 151 were living in residential CHs. The average resident was female 
(61.8%) and 82 years old (range: 24-103 years). Of the 3,715 medication items prescribed on MARs 
for each unique resident observed, medications in tablet or capsule form comprised 66.9% (n=2,487) 
of all items.  
Of the 41 different staff observed to be administering medications, 35 were female and 6 were male, 
35 were nurses and 6 were carers (Table 2). Observed staff had worked in CHs for a median of 72 
months (range: 3-336). Observed staff had obtained their original nursing or carer qualifications in 
the UK (n=17), Philippines (n=5), Romania (n=5), South Africa (n=3), Kenya (n=2), Pakistan (n=2), 
India (n=2), Spain (n=1), Nigeria (n=1), Greece (n=1) Poland (n=1), and unknown (n=1).  
Of the 2,452 doses observed, 1,385 were administered from OP and 1,067 were administered from 
MCAs, and 1,999 were administered in nursing CHs and 453 in residential CHs (Table 2). According to 
medication administration round, 1,633 doses were observed during breakfast, 273 during lunch, 
528 during dinner and 18 during extra morning or afternoon medication administration rounds.  
Of the 2,665 medication types observed to be administered (where certain combination medications 
were counted as two separate medication types e.g. vitamin and mineral combinations), the top five 
medication classes observed were analgesics (12.3%, n=327), vitamins (10.5%, n=279), minerals 
(7.2%, n=193), antithrombotic agents (7.1%, n=190) and medications for acid related disorders 
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(6.6%, n=176). Psycholeptics, such as antipsychotics, anxiolytics, hypnotics and sedatives, comprised 
3.3% (n=87) of observed administered medications. 
Of the 2,452 doses observed, 8.0% (n=196) of tablet doses were crushed (whether appropriate or 
not), 28.4% (n=696) were not observed (by nurses or carers) to be consumed by the resident, 3.1% 
(n=75) were refused by the resident, and 4.3% (n=105) were not signed for after medication 
administration.  
Medication administration errors 
One hundred and seventy eight doses did not correlate with information contained on the MARs (i.e. 
were MAEs). A total of 2,493 opportunities for error were identified, leading to an overall MAE rate 
of 7.1% (178/2,493) (Table 3). MAE rates ranged from 2.1% to 15.9% by CH (Table 2). 
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Table 3. Medication administration errors by type of medication administration system. 1 
 Total OP 
(from both OP-only CHs and 
CHs that used both OP and MCAs) 
MCA RR  
(95%CI, p value) 
OP 
(from OP-only CHs) 
Number of observed doses 2,452 1,385 1,067  1,051 
Number of omitted doses  41 21 6 13 
Opportunities for error (observed + 
omitted doses) 
2,493 1,406 1,073 1,064 
Number of MAEs* 178 131 33 86 
Rate of MAEs per number of 
opportunities for error (%) 
7.1 9.3 3.1 3.9  
(2.4 to 6.1, 
p<0.001) 
8.1 
OP - original packaging; MCA - multi-compartment compliance aid; MAE - medication administration error.  
*cannot infer which medication administration system the medication would have been administered from (as a result of the CH using both MCAs and 
OP), therefore 14 MAEs of omission could not be assigned to either MCA or OP 
2 
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A statistically significant higher MAE rate of 9.3% was seen for solid, orally administered medications 3 
in tablet or capsule form administered from OP (from OP-only CHs and CHs that used both MCAs and 4 
OP) when compared with 3.1% for MCAs (RR=3.9, 95%CI 2.4 to 6.1, p<0.001; see Table 3 and Table 5 
4). Similar differences were found when comparing the MAE rate between OP from OP-only CHs and 6 
MCAs, and when comparing MAE rates between OP and MCAs only considering CHs that used both 7 
MCAs and OP (Table 4). 8 
A statistically significant difference did not exist in MAE rates between OP from OP-only CHs and OP 9 
from CHs that used a combination of MCAs and OP, nor between CHs that administered medications 10 
from a single medication administration system (OP-only CHs) and CHs that used a combination of 11 
systems (MCAs and OP) (Table 4).  12 
The same conclusions were reached when the two (out of ten) residential CHs where carers 13 
administered medications instead of nurses (a potential confounding factor) were removed from 14 
analyses.  15 
In CHs that used a combination of MCAs and OP, a statistically significant difference did not exist in 16 
MAE rates between medications administered by carers and nurses for either MCA (RR for carers v. 17 
nurses=1.5, 95%CI 0.4 to 5.1, p=0.51), OP (RR=1.8, 95%CI 0.9 to 3.4, p=0.08) or overall medication 18 
administration (OP and MCAs) (RR=1.8, 95%CI 0.9 to 3.3, p=0.08).  19 
Residents’ age and gender and the type of medication administration round were not statistically 20 
significantly related to the MAE rate (data not shown). Compared to administering one medication 21 
dose, administering two or more doses resulted in a lower MAE rate (RR=0.643, 95%CI 0.41 to 0.97, 22 
p=0.043). None of the medication administrator factors (the length of their experience or their 23 
gender) and the duration of the medication administration round, were statistically significantly 24 
related to the MAE rate (data not shown). 25 
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Of the 178 doses observed to be administered (or omitted) in error, the top three most common 26 
MAE types included timing inaccuracy (2.9% error rate, n=73), omission (1.6%, n=41) and wrong 27 
dose (1.2%, n=29) (Table 5).  28 
  29 
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Table 4. Medication administration errors by source of medication administration system; relative risks comparing error risks between OP and MCA in OP-30 
only care homes and care homes that used both systems. 31 
Source of 
OP 
RR (95%CI) 
Source of  
MCA 
P value 
OP-only CHs CHs that used both OP and MCAs CHs that used both OP and MCAs  
3.9 (2.4 to 6.1) Reference <0.001 
2.3 (1.1 to 4.9)  Reference 0.03 
 4.3 (2.7 to 6.8) Reference <0.001 
Reference 1.8 (0.9 to 3.8)  0.10 
1.3 (0.6 to 2.7) Reference 0.44 
CH - care home; OP - original packaging; MCA - multi-compartment compliance aid; RR - relative risk. 
  32 
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Table 5. Medication administration error types. 33 
 OP 
 
Total opportunities for error = 
1,406 
MCA 
 
Total opportunities for error = 
1,073 
Unsure* 
 
Totals 
 
Total opportunities for error = 2,493 
(OP+MCA+unsure) 
n MAE rate % 
 
n MAE rate %  n MAE rate % 
Omission 21  1.5 6  0.6 14 41 1.6 
Allergy inaccuracy 0 0 4  0.4  4 0.2 
Wrong dose 24  1.7 5  0.5  29 1.2 
Un-prescribed 
medication 
3  0.2 0 0  3 0.1 
Medication incorrect 7  0.5 0 0  7 0.3 
Formulation incorrect 7  0.5 0 0  7 0.3 
Timing inaccuracy 57  4.1 16  1.5  73 2.9 
‘Other’  12  1.8 2  0.2  14 0.6 
24 
 
OP - original packaging; MCA - multi-compartment compliance aid; MAE - medication administration error. 
*cannot infer which medication administration system the medication would have been administered from (as a result of the CH using both 
MCAs and OP), therefore 14 MAEs of omission could not be assigned to either MCA or OP 
34 
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The top three most common World Health Organization Anatomical Therapeutic Chemical 
Classification System (ATC) codes involved in MAEs were anti-bacterials for systemic use (23.0%, 
n=41), anti-parkinson medications (22.5%, n=40) and analgesics (18.0%, n=32).  
A number of potential contributing factors (and the MAE types they contributed to) were observed, 
including: medications not supplied by the pharmacy or duplicate MAR medication entries 
(omission); administering a particular medication from both an MCA and an OP to the same 
individual (wrong dose); transcription errors between old and new MARs (un-prescribed 
medication); newly commenced medications not recorded on the MAR (un-prescribed medication); 
lengthy medication administration rounds (timing inaccuracy); delayed medication administration 
round start times (timing inaccuracy); administering medications with meals (‘other’ errors); and 
staff forgetting to administer bisphosphonate medications earlier in the day requiring later 
administration with other medications (‘other’). 
Five main barriers and related facilitators were identified during medication administration 
observations, involving the resident, workplace, pharmacy, medication trolley and MAR. Firstly, it 
was observed that residents did not always cooperate with staff administering medications and 
experienced unpredictable mood fluctuations that impacted on their level of cooperation. To 
overcome this barrier, staff administering medications familiarised themselves with individual 
resident medication-taking preferences (e.g. consuming medications with certain food or drink) and 
used strategies to encourage medication consumption (e.g. calming music). Secondly, staff 
administering medications were often interrupted, distracted and delayed. Interruptions and 
distractions were especially evident when administration occurred in communal living spaces such as 
the CH dining room, where other residents, CH staff or visitors could easily interrupt or distract staff 
administering medications. Additionally, medication administration was often delayed by residents 
receiving personal care. To overcome this barrier, medication trolleys were parked away from 
communal meeting areas, and staff who were providing personal care were notified of medication 
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administration schedules in advance. Thirdly, medications were sometimes missing from pharmacy 
deliveries, which CH staff promptly followed-up via telephone. Fourthly, medication trolleys were 
sometimes disorganised and lacked equipment necessary for medication administration. This barrier 
was overcome by staff ensuring that medication trolleys were adequately organised and equipped 
prior to leaving the medication room and commencing medication administration, and using items 
such as trays or buckets to facilitate organisation. Lastly, MARs were sometimes disorganised, or had 
unclear or inaccurate medication information. This barrier was overcome by staff allocating time to 
tidy MARs and editing information contained within them where necessary (including asking the 
pharmacy to assist with amendments). 
DISCUSSION 
This is the first published study specifically designed to compare, and subsequently identify a 
statistically significant difference in, the MAE rate between solid, orally administered medications in 
tablet or capsule form administered from OP and MCAs.  
The overall MAE rate identified in the current study (7.1%) is lower than that reported by others 
(8.4% - 21.7%).2, 7 This may be due to differences in the dosage forms observed (all dosage forms-
other studies, compared with only oral dosage forms-the present study), research professionals 
involved, definitions of MAE and research methods used. For example, Barker et al involved nurses 
and pharmacy technicians who directly observed MAEs in all administered medications;2 Szczepura 
et al used a disguised observation technique and analysis of deviations between prescribed 
medications and dispensed items prior to administration;19 Van den bemt et al also used a disguised 
observation technique and considered the lack of supervision of medication consumption as a 
MAE;20 and Scott-Cawiezell et al did not include ‘timing inaccuracy’ as an error.21 However, the top 
three types of MAE identified in the current study are similar to other studies.7, 19, 20 No statistically 
significant differences were observed in MAE rates between nursing and residential CHs, which is 
comparable to CHUMs,1 which used the same methodology as the current study. In contrast, 
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Szczepura et al found that the potential MAE rate was higher in nursing CHs compared to residential 
CHs.19 However, the current study was not designed to detect such a difference and only two 
residential CHs were included in the sample. 
The statistically significant difference in MAE rates between OP and MCAs remained, even when the 
potential confounding factor of using more than one medication administration system at the CH 
was considered in analyses, as well as the type of CH (nursing or residential). A significant difference 
in MAE rates was not identified when comparing medication administration between CHs that only 
used one medication administration system (OP) and CHs that used more than one system (OP and 
MCAs).  This indicates that using both OP and MCAs (as occurs in the majority of CHs in the UK) does 
not lead to significantly higher MAE rates. Additionally, this indicates that there are unique factors 
associated with using OP that contribute to their higher MAE rate. Future research should explore 
what these unique factors are (and how they influence MAEs), alongside one obvious factor of nurse 
or carer freedom of choice associated with administering medications from OP compared to pre-
prepared MCAs. Although this study was not designed to explore this, the study findings suggest a 
higher MAE rate (although not statistically significant) when carers administer medications 
compared to nurses (as is becoming increasingly common in UK CHs).  
Implications for policy and practice and further research  
This study provides direction to CH staff and pharmacy and nursing organisations that are involved in 
evaluation and quality improvement of CH medication administration systems. The overall MAE rate 
(7.1%) identified in administered tablets and capsules, which comprised the majority of prescribed 
medication forms contained on the MARs (66.9%), highlights that tablets and capsules are 
susceptible to MAEs, despite anecdotal perceptions that MAEs predominantly involve complex 
medication forms (e.g. injections, inhalers). Study findings support local CH policy and practice 
change that incorporates investigation of tablet and capsule impact on medication administration 
errors and staff training to prevent errors occurring. The significant difference in MAE rate between 
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OP and MCAs, highlights the importance of specifically targeting these medication administration 
systems in CH quality improvement activities.  Study findings support the use of MCAs in CHs that 
may be experiencing high MAE rates. Additionally, CH medication management guidelines, such as 
the National Institute for Health and Care Excellence Managing Medicines in Care Homes guidelines 
(written in the context of health and social care in England)22 and pharmacy guidelines12, 23, 24 could 
also include greater direction regarding MAEs that could result from using these systems. For 
example, a comprehensive list could be provided of the types of MAEs that can occur during 
medication administration (e.g. MAE types included in Table 1) and barriers that may contribute 
towards MAEs. Additionally, the lack of a significant difference in MAE rates between CHs that 
administered medications from a single medication administration system (OP-only) and CHs that 
used a combination of systems (OP and MCA), or between nurse and carer-administered 
medications, indicates that CHs can continue practicing medication administration using a 
combination of systems and staff qualifications, as is commonly seen in UK CHs, without being 
concerned about a significant increase in MAEs (compared to only using OP or nurse-administered 
medications). The finding that administering two or more doses resulted in a lower MAE rate 
warrants further research before it discourages CHs from exploring opportunities and benefits of de-
prescribing (reducing the number of medications a resident is prescribed). 
 A root cause analysis of identified MAEs was not conducted in this study. However, the five main 
barriers that were observed during medication administration provide important contextual 
information. While it is not certain whether these barriers influenced MAEs, it is clear that they did 
not facilitate the medication administration process. For example, if residents are uncooperative 
during medication administration and staff become flustered, they could fail to notice medication 
formulations as recorded in MARs and try to facilitate administration by crushing controlled-release 
medications (‘other MAE’). If staff are interrupted or distracted, they could lose their train of 
thought and inadvertently give double the dose of a medication (wrong dose). If pharmacies fail to 
supply the entire medication delivery, or medication trolleys are inadequately equipped with all 
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medications and staff do not notice, they could inadvertently omit a medication (omission). If MARs 
do not include clear information about medication administration times, staff could inadvertently 
administer medications at the wrong time of day (timing inaccuracy).  
Future research should involve a larger CH sample, across the UK, to determine whether observed 
barriers exist outside this study sample and the impact of these barriers on MAEs. A comprehensive 
list of strategies that can be used to overcome related barriers should be developed and shared 
among CHs. Additionally, when updating local medication administration CH policies and practices, it 
would be beneficial to explore what barriers exist and what local strategies can be implemented to 
overcome them. This proactive, facility-wide approach has the potential to more efficiently and 
effectively facilitate medication administration, as opposed to relying on individual CH staff to be 
aware of barriers and facilitative strategies and to put them into practice.  
Future research could consider the potential for pharmacists to observe medication administration 
rounds to gain a greater understanding of associated problems,25 and also explore potential risks 
associated with medication crushing and failing to observe medication consumption. Paradiso et al 
found that in 34% of medication administration observations in 10 Australian CHs, at least one 
medication was altered (e.g. crushed).26 Of these altered medications, 17% had the potential to 
cause increased toxicity, decreased efficacy, unpalatability, safety or stability concerns.26 It was 
recommended that regularly updated medication lists are developed, to highlight medications that 
should not be altered and alternative medication formulations that are available.26  
Strengths and limitations 
It is a strength that a large number of staff (n=42) were observed to administer medications to a 
large number of residents (n=823) over a large number of medication administration rounds (n=90). 
Additionally, this study involved a single research pharmacist directly observing medication 
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administration to identify MAEs compared to potentially less efficient and accurate methods of using 
nursing staff to review medication records and incident reports.4  
A small sample of CHs (10) located around Greater London was involved in this study, limiting 
generalisability of findings. Confounding factors that were not explored in this study (e.g. complexity 
of CH residents, education and training of CH staff, type of MCA or medication ordering system in 
use and the model of care provided by the CH) may have contributed to the wide and overlapping 
ranges of MAE rates between CHs that only used OP (2.1% to 15.9%) and CHs that used both OP and 
MCAs (3.6% to 13.0%). There is also the potential for researcher presence to influence the MAE rate, 
although this may not be a substantial bias.27 The clinical significance of MAEs was not determined in 
this study, however, there is currently no consensus on the relative importance of different types of 
MAE in CHs.19 Previous research has classified dispensing errors associated with preparing MCAs, 
according to their potential risk of causing an adverse event in the CH resident.28 Additionally, 
discrepancies were identified by comparing administered medications with the MAR (instead of the 
original medication prescription). Finally, this study did not observe medications other than for solid, 
orally administered tablets and capsules. Alldred et al identified that medication formulations other 
than tablets and capsules are particularly at risk of being administered incorrectly.29 Therefore the 
findings of this study alone cannot be used to determine the most appropriate medication 
administration system for individual CHs, especially by those considering changing their current 
system.30  
CONCLUSION 
The significant difference in, and high overall, medication administration error rate between original 
medication packaging and multi-compartment compliance aids supports the use of the latter in care 
homes, as well as local investigation of tablet and capsule impact on medication administration 
errors and staff training to prevent errors occurring. As a significant difference in error rate was not 
observed between use of a single or combination medication administration system, common 
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practice of using both multi-compartment compliance aids (majority of medications) and original 
packaging (medications with stability issues) is supported. Findings can inform local care home 
practice, as well as professional body and Government policies.  
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